PROC
- Procaps Group S.A.
()
Overview
Company Summary
Procaps Group S.A. (PROC) is a multinational company that operates in the pharmaceutical and healthcare industry. It specializes in the development, manufacturing, and distribution of advanced drug delivery systems and various healthcare products.
Procaps focuses on creating innovative solutions that improve patient outcomes and enhance medication adherence. Their core expertise lies in producing soft gelatin capsules, one-piece hard capsules, gels, creams, ointments, suppositories, and other specialized drug delivery technologies.
The company serves as a strategic partner for pharmaceutical and nutraceutical companies worldwide, offering comprehensive contract manufacturing services. This includes formulation development, scale-up, clinical production, packaging, and regulatory support.
Procaps has a broad product portfolio encompassing a wide range of therapeutic areas, including over-the-counter medications, prescription drugs, dietary supplements, and specialty healthcare products. They provide customized solutions tailored to meet specific client requirements throughout the product lifecycle.
Furthermore, Procaps is committed to sustainability and environmental responsibility. They prioritize reducing their ecological footprint through efficient manufacturing processes, waste management, and investing in renewable energy sources.
With a global presence, Procaps operates manufacturing facilities and sales offices in several countries, including Colombia, Brazil, Venezuela, Costa Rica, Peru, and the United States. This extensive network allows them to deliver high-quality products and services to their customers worldwide.
Overall, Procaps Group plays a vital role in the healthcare industry by developing and manufacturing advanced drug delivery systems and other healthcare products, helping to meet the evolving needs of patients and healthcare providers.